US Stock MarketDetailed Quotes

TCRX TScan Therapeutics

Watchlist

4.850
+0.080+1.68%

Close Dec 2 16:00 ET

4.750
-0.100-2.06%

Post 17:10 ET

258.85MMarket Cap-5105P/E (TTM)

TScan Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

TScan Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 1.381M	--
--	2024/Q4	-- / 1.510M	--
--	2024/Q3	1.049M / 1.173M	--
--	2024/Q2	536.000K / 1.819M	--
--	2024/Q1	566.000K / 4.300M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 1.381M--

--2024/Q4-- / 1.510M--

--2024/Q31.049M / 1.173M--

--2024/Q2536.000K / 1.819M--

--2024/Q1566.000K / 4.300M--

Unlock Free Earnings Estimates

Open Account

TScan Therapeutics Earnings Reports

TScan Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 12 12:26 ET

TScan Therapeutics | 8-K: TScan Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Nov 12 12:26 ET

TScan Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 12 07:35 ET

TScan Therapeutics | 8-K: TScan Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Aug 12 07:20 ET

Analyst Rating

Updated: Nov 30, 2024

Strong Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall